The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells

Free Radical Research

Volumn 43, Issue 4, 2009, Pages 323-328

  Lowes, Damon A ^a   Wallace, Carol ^a   Murphy, Michael P ^b   Webster, Nigel R ^a   Galley, Helen F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antibiotic; Coenzyme Q10; Idebenone; Mitochondria; MitoQ; Tendon

Indexed keywords

ANTIOXIDANT; CIPROFLOXACIN; DICHLORODIHYDROFLUORESCEIN; IDEBENONE; MITOCHONDRIA TARGETED UBIQUINONE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UBIQUINONE; UNCLASSIFIED DRUG; 10 (6' UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; 10-(6'-UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; HETEROCYCLIC COMPOUND; ORGANOPHOSPHORUS COMPOUND; QUINOLINE DERIVATIVE;

ACHILLES TENDON; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION; OXIDATIVE STRESS; TENDINITIS; TENDON RUPTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; INJURY; INTRACELLULAR MEMBRANE; METABOLISM; MITOCHONDRION; RUPTURE;

ACHILLES TENDON; ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; AZA COMPOUNDS; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; HUMANS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ORGANOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; QUINOLINES; RUPTURE; TENDINOPATHY; UBIQUINONE;

EID: 67650173968     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902736275     Document Type: Article

References (34)

1. Maffulli, N. and Kader, D. (2002) Tendinopathy of tendon achillis. J Bone Joint Surg, 84, pp. 1-8.
2. Bestwick, CS and Maffulli, N. (2004) Reactive oxygen species and tendinopathy: Do they matter?. Br J Sports Med, 38, pp. 672-674.
3. Goswami, M., Mangoli, SH and Jawali, N. (2006) Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother, 50, pp. 949-954.
4. Pouzaud, F., Bernard-Beaubois, K., Thevenin, M., Warnet, J-M, Hayem, G. and Rat, P. (2003) In vitro discrimination of fluoroquinolone toxicity on tendon cells: Involvement of oxidative stress. J Pharmacol Exp Ther, 308, pp. 394-402.
5. Shortt, P., Wilson, R. and Erskine, I. (2006) Tendinitis: The Achilles heel of quinolones!. Emerg Med J, 23, p. e63.
6. Corrao, G., Zambon, A., Bertu, L., Mauri, A., Paleari, V., Rossi, C. and Venegoni, M. (2006) Evidence of tendinitis provoked by fluoroquinolone treatment: A case-control study. Drug Saf, 29, pp. 889-896.
7. Burkhardt, O., Kohnlein, T., Pap, T. and Welte, T. (2004) Recurrent tendinitis after treatment with two different fluoroquinolones. Scand J Infect Dis, 36, pp. 315-316.
8. Ozaras, R., Mert, A., Tahan, V., Uraz, S., Ozaydin, I., Yilmaz, MH and Ozaras, N. (2003) Ciprofloxacin and Achilles' tendon rupture: A causal relationship. Clin Rheumatol, 22, pp. 500-501.
9. Reinberg, S. FDA mandates Black Box Warning for some antibiotics.
10. Bernard-Beaubois, K., Hecquet, C., Hayem, G., Rat, P. and Adolphe, M. (1998) In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol Toxicol, 14, pp. 283-292.
11. Williams, AC, Galley, HF and Webster, NR. (2005) Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother, 56, pp. 502-506.
12. Werber, S., Shalit, I., Fabian, I., Steuer, G., Weiss, T. and Blau, H. (2005) Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line. J Antimicrob Chemother, 55, pp. 293-300.
13. Burkhardt, O., Kohnlein, T., Pap, T. and Welte, T. (2004) Recurrent tendinitis after treatment with two different fluoroquinolones. Scand J Infect Dis, 36, pp. 315-316.
14. Ross, MF, Prime, TA, Abakumova, I., James, AM, Porteous, CM, Smith, RA and Murphy, MP. (2008) Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J, 411, pp. 633-645.
15. James, AM, Sharpley, MS, Manas, AR, Frerman, FE, Hirst, J., Smith, RA and Murphy, MP. (2007) Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem, 282, pp. 14708-14718.
16. James, AM, Cocheme, HM, Smith, RAJ and Murphy, MP. (2005) Interactions of mitochondria targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species: implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem, 280, pp. 21295-21312.
17. Esplugues, JV, Rocha, M., Nunez, C., Bosca, I., Ibiza, S., Herance, JR, Ortega, A., Serrador, JM, D'Ocon, P. and Victor, VM. (2006) Complex I dysfunction and tolerance to nitroglycerin: An approach based on mitochondrial targeted antioxidants. Circ Res, 99, pp. 1067-1075.
18. Jauslin, ML, Meier, T., Smith, RAJ and Murphy, MP. (2003) Mitochondria targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J, 17, pp. 1972-1974.
19. Maffulli, N., Ewan, SWB, Waterston, SW, Reaper, J. and Barrass, V. (2000) Tenocytes from ruptured and tendinopathic Achilles' tendon produced greater quantities of Type II collagen than tenocytes from normal Achilles' tendons. Am J Sports Med, 8, pp. 499-505.
20. Yao, L., Bestwick, CS, Bestwick, LA, Maffulli, N. and Aspden, RM. (2006) Phenotypic drift in human tenocyte culture. Tiss Eng, 12, pp. 1843-1849.
21. Qin, L., Block, ML, Liu, Y., Bienstock, RJ, Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T. and Hong, JS. (2005) Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J, 19, pp. 550-557.
22. Reers, M., Smith, TW and Chen, LB. (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry, 30, pp. 4480-4486.
23. Salvioli, S., Ardizzoni, A., Franceschi, C. and Cossarizza, A. (1997) JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. Febs Lett, 41, pp. 77-82.
24. Yang, TT, Sinai, P. and Kain, SR. (1996) An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells. Anal Biochem, 241, pp. 103-108.
25. Lowes, DA, Thottakam, BMV, Murphy, MP, Webster, NR and Galley, HF. (2008) The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med, 45, pp. 1559-1565.
26. Takayama, S., Hirohashi, M., Kato, M. and Shimada, H. (1995) Toxicity of quinolone antibacterial agents. J Toxicol Environ Health, 45, pp. 1-45.
27. Pouzaud, F., Dutot, M., Martin, C., Debray, M., Warnet, JM and Rat, P. (2006) Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells. Comp Biochem Physiol C Toxicol Pharmacol, 143, pp. 232-241.
28. Pouzaud, F., Christen, MO, Warnet, JM and Rat, P. (2004) Anethole dithiolethione: An antioxidant agent against tenotoxicity induced by fluoroquinolones. Pathol Biol, 52, pp. 308-313.
29. Gurbay, A., Garrel, C., Osman, M., Richard, MJ, Favier, A. and Hincal, F. (2002) Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum Exp Toxicol, 21, pp. 635-641.
30. Gurbay, A., Gonthier, B., Signorini-Allibe, N., Barret, L., Favier, A. and Hincal, F. (2006) Ciprofloxacin-induced DNA damage in primary culture of rat astrocytes and protection by Vitamin E. Neurotoxicology, 27, pp. 6-10.
31. Gurbay, A., Gonthier, B., Barret, L., Favier, A. and Hincal, F. (2007) Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E. Toxicology, 229, pp. 54-61.
32. Gurbay, A. and Hincal, F. (2004) Ciprofloxacin-induced glutathione redox status alterations in rat tissues. Drug Chem Toxicol, 27, pp. 233-242.
33. Simonin, MA, Gegout-Pottie, P., Minn, A., Gillet, P., Netter, P. and Terlain, B. (2000) Pefloxacin-induced achilles tendon toxicity in rodents: Biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother, 44, pp. 867-872.
34. Ross, MF, Prime, TA, Abakumova, I., James, AM, Porteous, CM, Smith, RA and Murphy, MP. (2008) Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J, 411, pp. 633-645.